Patients with lupus benefit from COVID-19 vaccine booster

People with systemic lupus erythematosus, or SLE, who received a 'booster' dose of SARS-CoV-2 vaccine after full vaccination are roughly half as likely to have a subsequent 'breakthrough' COVID-19 infection, a new study shows.